Dow Up 1.30% Nasdaq Up 0.37%

Celgene Corporation (CELG)

-NasdaqGS
106.94 Up 1.80(1.71%) 4:00PM EDT
|After Hours : 106.94 0.00 (0.00%) 6:45PM EDT
Prev Close:105.14
Open:104.70
Bid:106.80 x 100
Ask:106.97 x 100
1y Target Est:111.55
Beta:1.5
Next Earnings Date:N/A
Day's Range:104.18 - 107.35
52wk Range:66.85 - 107.35
Volume:5,770,246
Avg Vol (3m):4,801,680
Market Cap:85.50B
P/E (ttm):56.02
EPS (ttm):1.91
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Related Video

Comparison

Symbol% ChgMkt Cap
CELGUp 1.71%85.50B
JNJUp 1.40%301.88B

Key Statistics

Forward P/E (1 yr):21.87
P/S (ttm):11.45
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :3.69
Quarterly EPS Est (Dec-14) :1.00
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):1.09

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Celgene Corporation, a biopharmaceutical company, discovers, develops, and commercializes therapies to treat cancer and immune-inflammatory related diseases in the United States and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback